Replies to post #278352 on Amarin Corp Plc (AMRN)

[Lemmiwinks]

The prodigal son returns. I am actually and not sarcastically happy. Welcome back. Buy more. I guarantee 8 and maybe 42. Well said.
Lem

[Whalatane]

Hamoa ..thx for the analysis ...great to see U posting again

You posted

There are many, many ways new evidence makes it's way into an appeal, and Singer knows how to do that probably better than anyone in the world. Additionally, evidence that was not available at the time of the trial (which the JAMA paper purportes to disclose) is treated differently than known evidence that a party could have presented at trial but did not.

Kiwi

[Back2Deuce]

Hamoa, that’s very encouraging. Please continue to share your thoughts here as the saga continues to unfold and again welcome back.

[mrmainstreet]

Great to have you back Hamoa, many thanks for the analysis. The JAMA paper seems auspiciously released to say the least.

[circuitcity]

Great analysis and look forward to more. Great timing of analysis by GS too.

[Will Lar]

are you suggesting that Singer suggested/asked Bhatt et al to write this article?

If so, it's an interesting move indeed - let scientists comment on science, which is more convincing than the interpretation by legal staff (no offense here). With the brief pointing the legal procedural errors and the JAMA article pointing the scientific analysis errors, Amarin legal team provides the appeal court two strong arguments backed by experts in each field to reconsider the district ruling.

I assume that this article is not considered as "influencing federal judges."

Let's see how generics are making their case in their brief.

[alm2]

Sublime post Hamoa -wonderful to read the Informed legal voice of logic and reason
Intelligent investors in Amarin will take note of such
Alm

[iwishiknew]

Hamoa
Would the FC consider appointing a statistics rapporteur to advise the court - if the generics refused to accept a statistical error exists?

BTW, some say Bhatt analysis is for JAMA publication - I don't think so. Paper is on SSRN / Elsevier.

[MontanaState83]

Hamoa - Thank you for returning and please accept my apology as being one who turned you away. Emotion often gets the best of me and I vent in unproductive ways.

I also thought the timing of Bhatt’s paper interesting. (I.e. just as the generics are scrambling to finish their opening brief)

[venus537]

I agree with the first paragraph but everything after that sounds like wishful thinking especially the part about much rather being in Amarin's shoes.

[massulo52]

Welcome back, a great read!!!

[Bluensleepy]

Great assessment.

[dmiller]

This is what you get here 95% of the time. Take away the uncontrolled misguided emotions, conspiracy theories and ad hominem attacks and you are left with nothing around here.

I stepped away from iHub for a few weeks, as it seemed there wasn't much constructive or thoughtful discussion of Amarin going on here. Conspiracy theories and ad hominem attacks are not for me, nor do I think they're relevant to serious issues of concern to Amarin shareholders.

[Restingzebra]

Welcome back H. Great post. A pleasure to read, as always. Hope you don't let the annoyances keep you away. We all need you. All the best.

[Meowza]

Great post. Particularly insightful to connect Dr. Bhatt's new article directly with a potential mention in Singer's reply brief or oral arguments. This was the first concrete indication I've seen that may have been any gaps in Covington's original trial prep. Thank you for clearing up any confusion about evidence in appeals.